Lin BioScience Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-1,024	-744.27	-687.19	-313.52	-434.7	-151.84
Depreciation & Amortization	21.73	20.05	17.93	11.16	4.39	4.08
Other Amortization	0.43	0.16	-	-	-	-
Loss (Gain) From Sale of Assets	-	-	-	-	-0.22	-
Loss (Gain) From Sale of Investments	-10.12	-1.57	-	-	-	-
Stock-Based Compensation	700.07	291.06	115.15	44.39	8.91	0.93
Other Operating Activities	-893.16	-638.24	-378.32	-105.16	105.77	-22.4
Change in Accounts Receivable	-0.13	25.07	-25.02	1.46	-1.48	-
Change in Accounts Payable	-1.53	8.36	60.64	13.32	19.46	-7.23
Change in Other Net Operating Assets	51.9	20.08	-116.02	-12.66	8.02	-4.14
Operating Cash Flow	-1,155	-1,019	-1,013	-361.01	-289.84	-180.61
Capital Expenditures	-3.87	-5.82	-1.97	-22.38	-2.12	-0.57
Sale of Property, Plant & Equipment	-	-	-	-	0.51	-
Sale (Purchase) of Intangibles	-1.66	-1.53	-	-	-	-
Investment in Securities	-987.69	-3,612	-	-	-	-
Other Investing Activities	129.07	68.2	3.83	-1.67	0.13	0.78
Investing Cash Flow	-864.15	-3,551	1.87	-24.06	-1.48	0.2
Long-Term Debt Repaid	-	-14.63	-11.86	-5.53	-2.91	-2.83
Net Debt Issued (Repaid)	-15.93	-14.63	-11.86	-5.53	-2.91	-2.83
Issuance of Common Stock	751.02	98.38	622.41	511	31.23	915.26
Other Financing Activities	1,820	2,581	2,026	624.32	-	247.93
Financing Cash Flow	2,555	2,665	2,637	1,130	28.32	1,160
Foreign Exchange Rate Adjustments	-150.32	132.64	-10.14	93.66	-22.41	-4.85
Net Cash Flow	385.97	-1,773	1,616	838.39	-285.4	975.11
Free Cash Flow	-1,158	-1,025	-1,015	-383.4	-291.96	-181.18
Free Cash Flow Per Share	-14.47	-13.04	-13.72	-5.34	-4.24	-2.92
Cash Interest Paid	0.96	1	1.21	0.88	0.07	0.13
Cash Income Tax Paid	-	-69.4	-29.53	-18.4	-9.53	-23.02
Levered Free Cash Flow	-477.83	-573.21	-635.88	-658.48	-31.55	142.18
Unlevered Free Cash Flow	-477.23	-572.58	-635.13	-657.93	-31.5	142.33
Change in Working Capital	50.25	53.51	-80.39	2.12	26.01	-11.37

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.